| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioblastoma | 18 | 2024 | 265 | 4.820 |
Why?
|
| Neoplastic Stem Cells | 17 | 2019 | 161 | 4.430 |
Why?
|
| Brain Neoplasms | 17 | 2021 | 781 | 3.410 |
Why?
|
| Glioma | 15 | 2021 | 293 | 3.150 |
Why?
|
| Chordoma | 8 | 2021 | 20 | 2.180 |
Why?
|
| Caulobacter crescentus | 3 | 2019 | 9 | 1.360 |
Why?
|
| Protein Phosphatase 2 | 3 | 2018 | 16 | 1.320 |
Why?
|
| Meningeal Neoplasms | 2 | 2019 | 65 | 1.250 |
Why?
|
| Meningioma | 2 | 2019 | 63 | 1.250 |
Why?
|
| Signal Transduction | 15 | 2019 | 3373 | 1.210 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2018 | 88 | 1.180 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2019 | 470 | 1.160 |
Why?
|
| Cell Hypoxia | 3 | 2019 | 170 | 1.070 |
Why?
|
| Piperazines | 2 | 2018 | 283 | 1.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2017 | 155 | 0.970 |
Why?
|
| Radiation Tolerance | 2 | 2018 | 173 | 0.930 |
Why?
|
| Repressor Proteins | 7 | 2019 | 423 | 0.920 |
Why?
|
| Tumor Cells, Cultured | 11 | 2018 | 1057 | 0.910 |
Why?
|
| Central Nervous System Neoplasms | 3 | 2020 | 85 | 0.900 |
Why?
|
| Transcription Factors | 4 | 2019 | 1652 | 0.880 |
Why?
|
| Escherichia coli | 2 | 2017 | 605 | 0.850 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2019 | 213 | 0.830 |
Why?
|
| DNA-Binding Proteins | 5 | 2017 | 1241 | 0.750 |
Why?
|
| Dacarbazine | 3 | 2012 | 102 | 0.750 |
Why?
|
| Antineoplastic Agents | 8 | 2018 | 2411 | 0.730 |
Why?
|
| Tumor Hypoxia | 2 | 2017 | 30 | 0.730 |
Why?
|
| Membrane Proteins | 3 | 2019 | 1215 | 0.720 |
Why?
|
| ErbB Receptors | 4 | 2021 | 500 | 0.690 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2019 | 22 | 0.690 |
Why?
|
| Tumor Microenvironment | 5 | 2024 | 459 | 0.680 |
Why?
|
| Immunotherapy | 3 | 2019 | 669 | 0.670 |
Why?
|
| Metals, Heavy | 1 | 2019 | 15 | 0.650 |
Why?
|
| Mitochondria | 2 | 2019 | 553 | 0.640 |
Why?
|
| Bevacizumab | 3 | 2016 | 287 | 0.630 |
Why?
|
| Nanotubes | 1 | 2018 | 9 | 0.630 |
Why?
|
| Antibodies, Monoclonal, Humanized | 4 | 2020 | 967 | 0.620 |
Why?
|
| Metal Nanoparticles | 1 | 2018 | 31 | 0.620 |
Why?
|
| Metals, Rare Earth | 1 | 2017 | 2 | 0.610 |
Why?
|
| Gold | 1 | 2018 | 41 | 0.610 |
Why?
|
| Cell Culture Techniques | 4 | 2016 | 192 | 0.610 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 275 | 0.600 |
Why?
|
| Cell Proliferation | 12 | 2018 | 1650 | 0.600 |
Why?
|
| Digitoxin | 1 | 2017 | 3 | 0.600 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2017 | 5 | 0.590 |
Why?
|
| Mice, SCID | 5 | 2019 | 261 | 0.590 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 287 | 0.590 |
Why?
|
| Carbonic Anhydrases | 1 | 2017 | 15 | 0.580 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 540 | 0.570 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 125 | 0.570 |
Why?
|
| Antigens, CD | 4 | 2015 | 466 | 0.560 |
Why?
|
| Cell Line, Tumor | 12 | 2019 | 2552 | 0.560 |
Why?
|
| STAT3 Transcription Factor | 2 | 2014 | 85 | 0.560 |
Why?
|
| Mice | 18 | 2024 | 11737 | 0.550 |
Why?
|
| Benzazepines | 1 | 2016 | 64 | 0.540 |
Why?
|
| Transcription, Genetic | 3 | 2019 | 1157 | 0.540 |
Why?
|
| Animals | 27 | 2024 | 27317 | 0.530 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2015 | 18 | 0.520 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 665 | 0.520 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 887 | 0.510 |
Why?
|
| Cell Separation | 1 | 2016 | 198 | 0.510 |
Why?
|
| Loss of Heterozygosity | 1 | 2015 | 86 | 0.510 |
Why?
|
| Humans | 56 | 2021 | 89063 | 0.510 |
Why?
|
| Transplantation, Heterologous | 3 | 2015 | 370 | 0.500 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 92 | 0.490 |
Why?
|
| Protein Kinases | 2 | 2013 | 213 | 0.490 |
Why?
|
| Biomarkers, Tumor | 4 | 2018 | 1543 | 0.490 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2012 | 315 | 0.480 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 136 | 0.480 |
Why?
|
| Glycoproteins | 3 | 2011 | 234 | 0.480 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2015 | 54 | 0.470 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 397 | 0.470 |
Why?
|
| Serine | 1 | 2014 | 104 | 0.450 |
Why?
|
| Hypothalamic Neoplasms | 1 | 2012 | 2 | 0.420 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 387 | 0.410 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 183 | 0.410 |
Why?
|
| Peptides | 3 | 2011 | 646 | 0.410 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2012 | 47 | 0.400 |
Why?
|
| RNA, Small Interfering | 4 | 2019 | 557 | 0.390 |
Why?
|
| Vitamin A | 1 | 2011 | 28 | 0.390 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2012 | 138 | 0.390 |
Why?
|
| Vaccines | 2 | 2024 | 83 | 0.380 |
Why?
|
| Frontal Lobe | 1 | 2011 | 131 | 0.360 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 2362 | 0.360 |
Why?
|
| von Hippel-Lindau Disease | 2 | 2007 | 18 | 0.360 |
Why?
|
| Cerebellar Neoplasms | 2 | 2007 | 37 | 0.350 |
Why?
|
| AC133 Antigen | 4 | 2017 | 9 | 0.350 |
Why?
|
| Muir-Torre Syndrome | 1 | 2008 | 4 | 0.330 |
Why?
|
| RNA Interference | 3 | 2019 | 376 | 0.330 |
Why?
|
| Apoptosis | 5 | 2018 | 1716 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 421 | 0.310 |
Why?
|
| Spheroids, Cellular | 2 | 2018 | 31 | 0.300 |
Why?
|
| Cell Survival | 6 | 2018 | 982 | 0.290 |
Why?
|
| Hemangioblastoma | 1 | 2007 | 13 | 0.290 |
Why?
|
| Multipotent Stem Cells | 1 | 2007 | 19 | 0.290 |
Why?
|
| Phosphorylation | 4 | 2017 | 1130 | 0.290 |
Why?
|
| Stem Cells | 4 | 2010 | 372 | 0.280 |
Why?
|
| Uranium | 2 | 2017 | 8 | 0.270 |
Why?
|
| Female | 18 | 2020 | 46011 | 0.270 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 195 | 0.270 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 1087 | 0.270 |
Why?
|
| Astrocytoma | 3 | 2012 | 82 | 0.270 |
Why?
|
| Hypoxia | 1 | 2011 | 650 | 0.270 |
Why?
|
| Nuclear Proteins | 2 | 2008 | 726 | 0.260 |
Why?
|
| Neoplasms | 3 | 2018 | 3035 | 0.260 |
Why?
|
| Cell Differentiation | 5 | 2017 | 1521 | 0.250 |
Why?
|
| Middle Aged | 13 | 2020 | 25863 | 0.250 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2017 | 123 | 0.240 |
Why?
|
| Stress, Physiological | 2 | 2017 | 229 | 0.240 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 185 | 0.230 |
Why?
|
| Male | 20 | 2021 | 42251 | 0.220 |
Why?
|
| Neurons | 7 | 2012 | 1580 | 0.220 |
Why?
|
| Cell Movement | 2 | 2018 | 783 | 0.220 |
Why?
|
| Catheters, Indwelling | 2 | 2007 | 113 | 0.220 |
Why?
|
| Biomarkers | 5 | 2018 | 1755 | 0.210 |
Why?
|
| Protein Transport | 3 | 2017 | 421 | 0.210 |
Why?
|
| Cerebral Ventricles | 1 | 2002 | 78 | 0.210 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2020 | 170 | 0.200 |
Why?
|
| Telomerase | 1 | 2021 | 62 | 0.190 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2012 | 109 | 0.190 |
Why?
|
| Methotrexate | 1 | 2002 | 250 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 247 | 0.190 |
Why?
|
| Meningitis | 1 | 2020 | 20 | 0.180 |
Why?
|
| Thymoma | 1 | 2020 | 30 | 0.180 |
Why?
|
| Gene Expression | 3 | 2018 | 1310 | 0.180 |
Why?
|
| Thymus Neoplasms | 1 | 2020 | 43 | 0.180 |
Why?
|
| Lymphoma | 1 | 2002 | 265 | 0.180 |
Why?
|
| Ras Homolog Enriched in Brain Protein | 1 | 2019 | 1 | 0.170 |
Why?
|
| Staphylococcal Infections | 1 | 2002 | 269 | 0.170 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 43 | 0.170 |
Why?
|
| Monitoring, Immunologic | 1 | 2019 | 17 | 0.170 |
Why?
|
| Heterografts | 1 | 2019 | 102 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2019 | 43 | 0.170 |
Why?
|
| Immunohistochemistry | 5 | 2018 | 1796 | 0.170 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2018 | 1 | 0.170 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2018 | 7 | 0.170 |
Why?
|
| Microdialysis | 1 | 2019 | 32 | 0.160 |
Why?
|
| Biological Transport, Active | 1 | 2019 | 102 | 0.160 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 77 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 576 | 0.160 |
Why?
|
| Radiosurgery | 2 | 2012 | 280 | 0.160 |
Why?
|
| Organelle Biogenesis | 1 | 2018 | 6 | 0.160 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 10 | 0.160 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2018 | 57 | 0.160 |
Why?
|
| Nestin | 1 | 2018 | 18 | 0.160 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 71 | 0.160 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2018 | 31 | 0.160 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2020 | 261 | 0.160 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 360 | 0.150 |
Why?
|
| Mice, Nude | 2 | 2017 | 814 | 0.150 |
Why?
|
| Adult | 10 | 2021 | 26507 | 0.150 |
Why?
|
| Lanthanoid Series Elements | 1 | 2017 | 11 | 0.150 |
Why?
|
| Adsorption | 1 | 2017 | 54 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 956 | 0.150 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 69 | 0.150 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 169 | 0.150 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 273 | 0.150 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 20 | 0.150 |
Why?
|
| Gaucher Disease | 2 | 2007 | 4 | 0.150 |
Why?
|
| Endocytosis | 1 | 2018 | 180 | 0.140 |
Why?
|
| Combined Modality Therapy | 2 | 2012 | 1710 | 0.140 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 46 | 0.140 |
Why?
|
| Protein Binding | 2 | 2018 | 1487 | 0.140 |
Why?
|
| Proteasome Inhibitors | 1 | 2016 | 52 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 490 | 0.140 |
Why?
|
| Copper | 1 | 2017 | 77 | 0.140 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 22 | 0.140 |
Why?
|
| Zinc | 1 | 2017 | 93 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 106 | 0.140 |
Why?
|
| Oxidative Stress | 1 | 2019 | 458 | 0.140 |
Why?
|
| Dexamethasone | 1 | 2018 | 344 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2018 | 277 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 153 | 0.130 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2013 | 57 | 0.130 |
Why?
|
| Ligands | 1 | 2017 | 443 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 358 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2007 | 98 | 0.130 |
Why?
|
| Enzyme Activation | 1 | 2017 | 698 | 0.130 |
Why?
|
| Neurosurgical Procedures | 2 | 2016 | 232 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2020 | 3443 | 0.130 |
Why?
|
| Angiopoietin-2 | 2 | 2013 | 17 | 0.130 |
Why?
|
| Paresis | 2 | 2012 | 15 | 0.130 |
Why?
|
| Epidermal Growth Factor | 2 | 2013 | 117 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 280 | 0.130 |
Why?
|
| Rats | 6 | 2012 | 4040 | 0.130 |
Why?
|
| Brain | 4 | 2010 | 2281 | 0.130 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 309 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2015 | 22 | 0.120 |
Why?
|
| Microsatellite Repeats | 1 | 2015 | 147 | 0.120 |
Why?
|
| Cytokines | 1 | 2019 | 802 | 0.120 |
Why?
|
| Intracranial Aneurysm | 1 | 2016 | 175 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 364 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 1214 | 0.120 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 141 | 0.120 |
Why?
|
| Collagen Type I | 1 | 2015 | 72 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1429 | 0.120 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 174 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 374 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 299 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 2552 | 0.120 |
Why?
|
| bcl-X Protein | 1 | 2014 | 54 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2019 | 8203 | 0.120 |
Why?
|
| Hydroquinones | 1 | 2013 | 8 | 0.120 |
Why?
|
| DNA Footprinting | 1 | 2013 | 18 | 0.110 |
Why?
|
| Regulon | 1 | 2013 | 17 | 0.110 |
Why?
|
| Deoxyribonuclease I | 1 | 2013 | 28 | 0.110 |
Why?
|
| Benzoquinones | 1 | 2013 | 27 | 0.110 |
Why?
|
| Biopsy | 2 | 2020 | 1182 | 0.110 |
Why?
|
| Bacteria | 1 | 2017 | 472 | 0.110 |
Why?
|
| Brain Stem | 2 | 2020 | 167 | 0.110 |
Why?
|
| Quinazolines | 1 | 2015 | 221 | 0.110 |
Why?
|
| Janus Kinase 1 | 1 | 2013 | 16 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 481 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2016 | 1265 | 0.110 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2010 | 30 | 0.110 |
Why?
|
| Carbon | 1 | 2013 | 90 | 0.110 |
Why?
|
| Ciliary Neurotrophic Factor Receptor alpha Subunit | 1 | 2012 | 1 | 0.110 |
Why?
|
| Phenotype | 2 | 2017 | 2439 | 0.110 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2012 | 21 | 0.110 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2013 | 103 | 0.110 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 80 | 0.110 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 1591 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 695 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 859 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2014 | 200 | 0.100 |
Why?
|
| Cerebral Angiography | 1 | 2012 | 197 | 0.100 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2012 | 138 | 0.100 |
Why?
|
| Brain Edema | 1 | 2012 | 58 | 0.100 |
Why?
|
| Astrocytes | 1 | 2012 | 141 | 0.100 |
Why?
|
| Carotenoids | 1 | 2011 | 15 | 0.100 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 2 | 2010 | 23 | 0.100 |
Why?
|
| Hydrocephalus | 1 | 2012 | 104 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 340 | 0.100 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 221 | 0.090 |
Why?
|
| Binding Sites | 1 | 2013 | 1117 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 1012 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2012 | 727 | 0.090 |
Why?
|
| Proteomics | 2 | 2009 | 230 | 0.090 |
Why?
|
| Cholera Toxin | 1 | 2010 | 21 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 604 | 0.090 |
Why?
|
| beta Catenin | 1 | 2012 | 266 | 0.090 |
Why?
|
| Peptide Mapping | 1 | 2009 | 26 | 0.090 |
Why?
|
| Child | 3 | 2021 | 7149 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2012 | 794 | 0.090 |
Why?
|
| Mutation | 3 | 2021 | 4132 | 0.090 |
Why?
|
| Hyaluronan Receptors | 1 | 2009 | 38 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 85 | 0.090 |
Why?
|
| Protein Array Analysis | 2 | 2007 | 52 | 0.080 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2009 | 72 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 45 | 0.080 |
Why?
|
| Hippocampus | 1 | 2012 | 447 | 0.080 |
Why?
|
| Fetus | 1 | 2010 | 232 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2014 | 551 | 0.080 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2008 | 33 | 0.080 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2008 | 30 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2009 | 86 | 0.080 |
Why?
|
| Salvage Therapy | 1 | 2010 | 235 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 267 | 0.080 |
Why?
|
| Craniotomy | 1 | 2009 | 88 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 485 | 0.080 |
Why?
|
| Cells, Cultured | 5 | 2012 | 2880 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2009 | 229 | 0.080 |
Why?
|
| Aging | 1 | 2012 | 716 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 887 | 0.080 |
Why?
|
| Dopamine | 1 | 2009 | 276 | 0.070 |
Why?
|
| Chromogranin B | 1 | 2007 | 1 | 0.070 |
Why?
|
| Time Factors | 1 | 2016 | 5320 | 0.070 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 2007 | 6 | 0.070 |
Why?
|
| Gastric Bypass | 1 | 2009 | 110 | 0.070 |
Why?
|
| Pons | 1 | 2007 | 25 | 0.070 |
Why?
|
| Okadaic Acid | 1 | 2007 | 10 | 0.070 |
Why?
|
| CD13 Antigens | 1 | 2007 | 5 | 0.070 |
Why?
|
| Cell Degranulation | 1 | 2007 | 14 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 645 | 0.070 |
Why?
|
| Glucosylceramidase | 1 | 2006 | 2 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 2007 | 49 | 0.070 |
Why?
|
| Convection | 1 | 2006 | 12 | 0.070 |
Why?
|
| RNA, Neoplasm | 1 | 2007 | 88 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 313 | 0.070 |
Why?
|
| Pedigree | 1 | 2008 | 969 | 0.070 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2007 | 81 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2007 | 306 | 0.070 |
Why?
|
| Tretinoin | 1 | 2007 | 128 | 0.070 |
Why?
|
| Perfusion | 1 | 2007 | 235 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2009 | 233 | 0.070 |
Why?
|
| HLA-DR Antigens | 1 | 2005 | 59 | 0.070 |
Why?
|
| Young Adult | 2 | 2015 | 6288 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 2657 | 0.060 |
Why?
|
| Primates | 1 | 2006 | 155 | 0.060 |
Why?
|
| Neoplasm Grading | 2 | 2018 | 372 | 0.060 |
Why?
|
| Dendritic Cells | 2 | 2024 | 442 | 0.060 |
Why?
|
| Haplotypes | 1 | 2005 | 637 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2005 | 272 | 0.050 |
Why?
|
| Immunity | 1 | 2024 | 141 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2012 | 1237 | 0.050 |
Why?
|
| Time | 1 | 2002 | 76 | 0.050 |
Why?
|
| Aged | 2 | 2020 | 19077 | 0.050 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2002 | 7 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2275 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2002 | 73 | 0.050 |
Why?
|
| Fetal Proteins | 1 | 2021 | 17 | 0.050 |
Why?
|
| Receptor, TIE-2 | 2 | 2010 | 18 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 594 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2021 | 124 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 3657 | 0.040 |
Why?
|
| Cell Division | 2 | 2011 | 696 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2019 | 51 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 266 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2019 | 122 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 323 | 0.040 |
Why?
|
| Electron Transport Complex I | 1 | 2018 | 30 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 53 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2019 | 107 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2018 | 232 | 0.040 |
Why?
|
| Imidazoles | 1 | 2018 | 148 | 0.040 |
Why?
|
| Ipilimumab | 1 | 2018 | 61 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2021 | 439 | 0.040 |
Why?
|
| CTLA-4 Antigen | 1 | 2018 | 139 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 187 | 0.040 |
Why?
|
| Glycolysis | 1 | 2018 | 135 | 0.040 |
Why?
|
| Adolescent | 2 | 2007 | 9237 | 0.040 |
Why?
|
| DNA Damage | 1 | 2019 | 371 | 0.040 |
Why?
|
| DNA Repair | 1 | 2019 | 362 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2019 | 451 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2018 | 511 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1714 | 0.040 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 20 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 71 | 0.030 |
Why?
|
| Pyridines | 1 | 2018 | 315 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2016 | 114 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 638 | 0.030 |
Why?
|
| Truth Disclosure | 1 | 1996 | 93 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2018 | 372 | 0.030 |
Why?
|
| Disclosure | 1 | 1996 | 110 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 749 | 0.030 |
Why?
|
| Medical Errors | 1 | 1996 | 117 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2016 | 165 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2015 | 202 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 242 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2015 | 148 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 889 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 465 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2014 | 208 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 2001 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 78 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 616 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2007 | 9003 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 65 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 342 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2014 | 253 | 0.030 |
Why?
|
| Cell Count | 1 | 2012 | 200 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1363 | 0.030 |
Why?
|
| Neuroglia | 1 | 2012 | 105 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 58 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2014 | 519 | 0.030 |
Why?
|
| Solubility | 1 | 2012 | 179 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 106 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 1108 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 1488 | 0.030 |
Why?
|
| Headache | 1 | 2012 | 72 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2012 | 99 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1400 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 2752 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 524 | 0.020 |
Why?
|
| Laminin | 1 | 2011 | 89 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 152 | 0.020 |
Why?
|
| Steroids | 1 | 2012 | 174 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 3773 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1975 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2010 | 34 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 628 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 132 | 0.020 |
Why?
|
| Haplorhini | 1 | 2010 | 81 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 2009 | 39 | 0.020 |
Why?
|
| Base Sequence | 1 | 2014 | 2327 | 0.020 |
Why?
|
| Electrophoresis, Capillary | 1 | 2009 | 12 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 29 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2009 | 34 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2011 | 291 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1763 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 447 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2010 | 82 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2009 | 47 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2009 | 94 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 193 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 272 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 197 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 170 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2012 | 409 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 262 | 0.020 |
Why?
|
| Histones | 1 | 2010 | 329 | 0.020 |
Why?
|
| Dissection | 1 | 2008 | 44 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 387 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2008 | 74 | 0.020 |
Why?
|
| Facial Paralysis | 1 | 2007 | 17 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 511 | 0.020 |
Why?
|
| Catecholamines | 1 | 2007 | 92 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2007 | 84 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 27 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 2006 | 35 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2007 | 264 | 0.020 |
Why?
|
| HLA-DR Serological Subtypes | 1 | 2005 | 1 | 0.020 |
Why?
|
| HLA-DRB5 Chains | 1 | 2005 | 1 | 0.020 |
Why?
|
| HLA-DRB1 Chains | 1 | 2005 | 25 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 1239 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 3209 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2007 | 227 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2006 | 159 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2006 | 261 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 306 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2005 | 126 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2005 | 153 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2005 | 197 | 0.020 |
Why?
|
| Radiography | 1 | 2006 | 809 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2006 | 466 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 911 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 691 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2005 | 471 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 1090 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 2476 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 3147 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2011 | 0.010 |
Why?
|
| Compensation and Redress | 1 | 1996 | 4 | 0.010 |
Why?
|
| Jurisprudence | 1 | 1996 | 25 | 0.010 |
Why?
|
| Liability, Legal | 1 | 1996 | 32 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1996 | 187 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 1996 | 385 | 0.010 |
Why?
|
| Internal Medicine | 1 | 1996 | 355 | 0.010 |
Why?
|
| United States | 1 | 1996 | 6955 | 0.000 |
Why?
|